PCR fluorescence
-
ʻO ka waikawa nukleika Helicobacter Pylori
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka qualitative in vitro o ka helicobacter pylori nucleic acid i loko o nā laʻana biopsy mucosal gastric a i ʻole nā laʻana lawai o nā maʻi i manaʻo ʻia he maʻi me ka helicobacter pylori, a hāʻawi i kahi mea kōkua no ka ʻike ʻana o nā maʻi me ka maʻi helicobacter pylori.
-
Pahu ʻIke STI Multiplex 7
Kōmike Huahana
HWTS-UR012
Hoʻohana i manaʻo ʻia
Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i nā pathogens maʻamau o nā maʻi urogenital, me Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU), Herpes Simplex Virus Type 1 (HSV1), Herpes Simplex Virus Type 2 (HSV2), Mycoplasma hominis (Mh), Mycoplasma genitalium (Mg) i loko o nā ʻāpana mimi kāne a me nā ʻāpana wahine.
-
ʻO ka maʻi Hepatitis C RNA Nucleic Acid
ʻO ka HCV Quantitative Real-Time PCR Kit he hoʻāʻo Nucleic Acid (NAT) in vitro e ʻike a helu i nā waikawa nucleic Hepatitis C Virus (HCV) i loko o nā laʻana plasma koko kanaka a i ʻole serum me ke kōkua o ke ʻano Quantitative Real-Time Polymerase Chain Reaction (qPCR).
-
Ka Hoʻohālikelike ʻana o ka Maʻi Hepatitis B
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ke ʻano qualitative o ke ʻano B, ke ʻano C a me ke ʻano D i loko o nā laʻana serum/plasma maikaʻi o ka maʻi hepatitis B (HBV)
-
Ka maʻi Hepatitis B
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka nui o ka waikawa nucleic hepatitis B i loko o nā laʻana serum kanaka.
-
ʻO Chlamydia Trachomatis, Ureaplasma Urealyticum a me ka waikawa nucleic Neisseria Gonorrhoeae
He kūpono kēia pahu hana no ka ʻike ʻana i nā pathogens maʻamau i nā maʻi urogenital in vitro, me Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU), a me Neisseria gonorrhoeae (NG).
-
ʻO ka maʻi Herpes Simplex ʻAno 2 Nucleic Acid
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka herpes simplex virus type 2 nucleic acid i loko o nā hāpana swab urethral kāne a me nā hāpana swab cervical wahine.
-
ʻO ka waikawa nukleika Chlamydia Trachomatis
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka Chlamydia trachomatis nucleic acid i loko o ka mimi kāne, ka swab urethral kāne, a me nā hāpana swab cervical wahine.
-
ʻO Enterovirus Universal, EV71 a me CoxA16
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka enterovirus, EV71 a me CoxA16 nucleic acids in vitro i loko o nā swabs ʻāʻī a me nā laʻana wai herpes o nā maʻi me ka maʻi lima-wāwae-waha, a hāʻawi i kahi ala kōkua no ka ʻike ʻana i nā maʻi me ka maʻi lima-wāwae-waha.
-
ʻEono ʻano o nā maʻi hanu
Hiki ke hoʻohana ʻia kēia pahu hana e ʻike pono i ka waikawa nucleic o SARS-CoV-2, ka maʻi influenza A, ka maʻi influenza B, adenovirus, mycoplasma pneumoniae a me ka maʻi respiratory syncytial in vitro.
-
Ka ʻIke ʻana i ka Nucleic Acid Group B Streptococcus (EPIA)
Hoʻohana ʻia kēia pahu e ʻike pono i ka hui B streptococcus nucleic acid DNA i loko o nā swabs rectal vitro, nā swabs vaginal a i ʻole nā swabs hui rectal / vaginal o nā wahine hāpai me nā mea pilikia kiʻekiʻe ma kahi o 35 ~ 37 mau pule o ka hāpai ʻana, a me nā pule gestational ʻē aʻe me nā hōʻailona lapaʻau e like me ka haki mua ʻana o nā membranes, hoʻoweliweli i ka hana preterm, a pēlā aku.
-
ʻO AdV Universal a me ka ʻAno 41 Nucleic Acid
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative in vitro o ka adenovirus nucleic acid i loko o nā swabs nasopharyngeal, nā swabs ʻāʻī a me nā laʻana ʻōpala.
